Literature DB >> 1968405

Defective epidermal growth factor gene expression in mice with polycystic kidney disease.

V H Gattone1, G K Andrews, F W Niu, L J Chadwick, R M Klein, J P Calvet.   

Abstract

The C57BL/6J-cpk mouse has an inheritable form of polycystic kidney disease similar to the autosomal recessive disorder seen in humans. Between approximately 1 and 3 weeks of age, affected cpk mice develop numerous large cysts in the collecting tubule segment of kidney nephrons. The present study examined the ontogeny of renal and submandibular gland prepro-epidermal growth factor (preproEGF) gene expression in the cpk mouse using Northern blot hybridization and immunohistochemistry. There was a virtual absence of renal preproEGF gene expression in cystic kidneys over the 3-week postnatal period, during which time renal preproEGF mRNA and proEGF/EGF protein normally reach significant levels. PreproEGF mRNA was expressed in salivary glands of cystic mice; however, this mRNA could not be further elevated with testosterone suggesting that there are abnormalities in the regulation of the preproEGF gene in the submandibular gland, as well as in the kidney. Since renal preproEGF expression during the early postnatal period occurs when collecting duct cysts form, it is possible that a deficiency in renal proEGF or EGF contributes to the rapid development of collecting duct cysts and the concomitant renal failure in the C57BL/6J-cpk cystic mouse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968405     DOI: 10.1016/0012-1606(90)90192-l

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  11 in total

Review 1.  Polypeptide growth factors and the kidney: a developmental perspective.

Authors:  E D Avner
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

Review 2.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

4.  A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.

Authors:  R Pey; J Bach; G Schieren; N Gretz; M Hafner
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

5.  Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease.

Authors:  W G Richards; W E Sweeney; B K Yoder; J E Wilkinson; R P Woychik; E D Avner
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 6.  Diagnosis, pathogenesis, and treatment prospects in cystic kidney disease.

Authors:  Carsten Bergmann; Valeska Frank; Fabian Küpper; Dirk Kamitz; Jens Hanten; Peter Berges; Silke Mager; Markus Moser; Jutta Kirfel; Reinhard Büttner; Jan Senderek; Klaus Zerres
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

8.  Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.

Authors:  Yasunori Sato; Kenichi Harada; Kazuo Kizawa; Takahiro Sanzen; Shinichi Furubo; Mitsue Yasoshima; Satoru Ozaki; Masahiko Ishibashi; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

9.  Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration.

Authors:  I A Atencio; F F Shadan; X J Zhou; N D Vaziri; L P Villarreal
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Basement membrane chondroitin sulfate proteoglycan alterations in a rat model of polycystic kidney disease.

Authors:  T Ehara; F A Carone; K J McCarthy; J R Couchman
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.